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Abstract We aimed to explore whether vegetable con-
sumption according to guidelines has beneficial health
effects determined with classical biomarkers and nutrige-
nomics technologies. Fifteen lean (age 36 ± 7 years; BMI
23.4 ± 1.7 kg m-2) and 17 obese (age 40 ± 6 years; BMI
30.3 ± 2.4 kg m-2) men consumed 50- or 200-g vegeta-
bles for 4 weeks in a randomized, crossover trial. After-
ward, all subjects underwent 4 weeks of energy restriction
(60 % of normal energy intake). Despite the limited weight
loss of 1.7 ± 2.4 kg for the lean and 2.1 ± 1.9 kg for the
obese due to energy restriction, beneficial health effects
were found, including lower total cholesterol, LDL cho-
lesterol and HbA1c concentrations. The high vegetable
intake resulted in increased levels of plasma amino acid
metabolites, decreased levels of 9-HODE and prostaglan-
din D3 and decreased levels of ASAT and ALP compared
to low vegetable intake. Adipose tissue gene expression
changes in response to vegetable intake were identified,
and sets of selected genes were submitted to network
analysis. The network of inflammation genes illustrated a
central role for NFkB in (adipose tissue) modulation of
inflammation by increased vegetable intake, in lean as well
as obese subjects. In obese subjects, high vegetable intake
also resulted in changes related to energy metabolism,
adhesion and inflammation. By inclusion of sensitive omics
technologies and comparing the changes induced by high
vegetable intake with changes induced by energy restric-
tion, it has been shown that part of vegetables’ health
benefits are mediated by changes in energy metabolism,
inflammatory processes and oxidative stress.
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Introduction
Consumption of vegetables is generally considered to be
associated with several positive effects on health. It has
been shown that low consumption of fruit and vegetables is
related to more cardiovascular disease and cancer (Krebs-
Smith and Kantor 2001; Lock et al. 2005; Martinez-Gon-
za´lez et al. 2011; Mosby et al. 2012). Vegetables are a
heterogeneous group of our diet with a low energy density
and rich in bio-active compounds, such as vitamins, min-
erals, dietary fibers and phytochemicals like flavonoids and
carotenoids (Toma´s-Barbera´n and Robins 1997; Yao et al.
2004; Martinez-Gonza´lez et al. 2011; Mosby et al. 2012).
The recommended intake of vegetables by the Dutch
Health Council is 150–200 g daily (Health Council of the
Netherlands 2006). However, it has been reported that only
2 % of the Dutch population meets the recommended daily
intake of 150 g of vegetables (Health Council of the
Netherlands 2006).
Conflicting results of vegetables have been found in
epidemiological studies. Studies with large cohorts of
subjects, often report reduced risks for certain diseases
when vegetable consumption was increased. The World
Cancer Research Fund reported in 2007 that diets
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containing substantial and varied amounts of vegetable and
fruit intake (at least 400 g/day) will prevent 20 % or more
of all cancer cases (WCRF 2007). Also, cardiovascular
disease risks are lower in subjects consuming more fruit
and vegetables. In a meta-analysis of Hu, it was found that
consumption of green leafy vegetables had protective
effects for coronary heart disease (Hu 2003). Cruciferous
vegetables and vitamin C rich citrus fruit and juices were
found to protect against stroke (Hu 2003). Also, the
development of diabetes mellitus may be reduced with
vegetable consumption (Bazzano et al. 2008; Villegas et al.
2008). Several specific compounds present in vegetables
have been studied for their potential beneficial effects:
antioxidants (especially polyphenols, lycopene and vitamin
C) as free radical trapper; dietary fiber for its effect on
gastro-intestinal functioning and related satiety; and gluc-
osinolates present in the Brassicaceae vegetables family
(cabbage; Brussels sprouts; cauliflower; broccoli), for their
chemopreventive effect against cancer (Hayes et al. 2008).
Based on epidemiological data, most national guidelines
prescribe consumption of at least 200 g of vegetables and
two pieces of fruit daily. The European Prospective
Investigation into Cancer and Nutrition (the EPIC study)
reported, however, no protective effect of total or specific
vegetables intake against different types of cancer, like
gastric cancer or urothelial cell carcinoma (Gonzalez et al.
2012; Ros et al. 2012).
Therefore, the inverse relationship of vegetable intake
and disease risk is complex, also in relation to obesity.
Vegetable consumption correlates with a lower risk of
obesity (Martin et al. 2011; Myint et al. 2011), while
increased body weight is related to increased risk of cancer
(Wolin et al. 2010; La Vecchia et al. 2011), coronary (the
Emerging Risk Factors Collaboration, 2011; Yusuf et al.
2005) and metabolic diseases (Boden 2008; Abdullah et al.
2010). Weight loss of 5–10 % of the initial body weight
has been shown to improve risk profiles of diseases related
to obesity (Wing et al. 1992; Tuomilehto et al. 2001). Also,
weight loss due to caloric restriction will lead to changes in
adipose tissue (Ma´rquez-Quin˜ones et al. 2010; Bouchard
et al. 2010).
Measuring the effects of a nutritional intervention such
as increased vegetable intake is difficult, as the effects are
likely to be subtle and variable across subjects. We and
others have demonstrated that integration of omics tech-
nologies in nutrition research can yield more insights into
effects of nutrition on health-related physiological pro-
cesses (van Erk et al. 2008; Radonjic et al. 2009; Bakker
et al. 2010).
The mechanisms of action for the vegetable intervention
and the energy restriction on health may differ. High
vegetable intake has been suggested to be mainly anti-
inflammatory due to its high antioxidant content (Calder
et al. 2011). It is also possible that certain phenolic com-
pounds of fruits and vegetables may also have some caloric
restriction mimetic effects if they activate sirtuin deacety-
lases (Chen et al. 2008). Energy restriction will limit the
effects of energy-driven processes like oxidative phos-
phorylation, mitochondrion activity, generation of precur-
sor metabolites and energy (Calder et al. 2011).
In the present study, the effect of high vegetable con-
sumption was investigated in a crossover trial by compar-
ing this to low vegetable consumption in both lean and
obese subjects. An energy-restricted dietary intervention
was conducted in a parallel design after the crossover part,
to examine whether part of the effects of vegetables may be
attributed to similar mechanisms.
We performed a large-scale assessment of changes in a
range of blood parameters using sensitive (omics) tech-
niques. Analyses included the profiling of cytokines, amino
acids and oxylipins to monitor the effect of the vegetable
intervention on processes related to inflammation, oxida-
tive stress, beta-oxidation and protein and amino acid
metabolism. Furthermore, we assessed effects on adipose
tissue by transcriptome analysis of adipose tissue biopsies.
Interpretation of effects of high vegetable intake in light of
effects induced by energy restriction gives additional
insight into health-promoting effects of vegetables.
Methods
Study design
The study was a combination of a crossover trial for the
vegetable intervention and a parallel setup for the third
period. This was an energy-restricted diet intervention for
all subjects.
Each intervention period lasted 4 weeks. With the high
vegetable treatment, subjects consumed 200 g of vegeta-
bles daily, and with the low vegetable treatment, subjects
consumed 50 g of vegetables daily. Subjects were free to
consume their vegetables with lunch and/or with dinner.
The vegetables were provided weekly by TNO; about ten
different, most popular vegetables could be chosen; fresh
vegetables for the first and second day of the week
(tomatoes; beet; onions; cauliflower) and canned vegeta-
bles for the rest of the week [peas; carrots; French beans;
broad beans; corn (mixture)]. Each type of vegetable could
be chosen only once a week to guarantee a variation in the
diet. Intake of fruit was limited to one piece a day to
prevent confounding effects. Further food intake and life-
style were maintained as usual.
The amount of food consumed during the energy-
restricted diet intervention was based on the food intake
diaries during the crossover interventions. All subjects
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were instructed to consume about 60 % of their normal
energy intake. A dietitian advised the subjects and moni-
tored compliance.
The energy-restricted intervention was added as a
positive control for vegetable treatment because of its
known beneficial effects on health. Due to the expected
weight loss in the energy-restricted period, no complete
crossover design was applied in the study, because the
effect of weight loss is expected to effect the next
treatment.
The study was conducted at TNO (Zeist, the Nether-
lands). The study was approved by an independent cen-
tralized ethics committee (METOPP, Tilburg, the
Netherlands) and is registered at Clinicaltrials.gov, number
NCT 00959790.
After inclusion, subjects were randomly allocated to
entry number and study treatment (vegetable dose order),
in such a way that age and BMI were equally divided
among treatment groups.
The study was designed as an open study, so subjects
and investigators were aware of the dosage of vegetables
consumed. The energy intake was different between the
two vegetable treatments: in the 200-g vegetable inter-
vention, about 30–70 kcal was consumed with vegetable
consumption, whereas this was 15–35 kcal for vegetables
in the 50-g vegetable intervention. This difference in
energy intake was part of the intervention (the difference in
energy intake is about 15–55 kcal/day; 0.5–1.0 % of the
habitual daily energy intake (about 3,000 kcal for males/
day)). No energy compensation occured as could be con-
cluded from the maintenance of body weights.
The difference of 150-g vegetable consumption affected
the intake of vitamins and minerals; vitamin C (26 mg),
vitamin B (total about 0.4 mg), lycopene (153 lg), retinol
equivalents (360 RE), lutein (1,473 lg), sodium (71 mg),
potassium (345 mg), calcium (65 mg), phosphorus
(69 mg), magnesium (23 mg) and iron (69 mg) differed
mostly between the two treatment dosages. The subjects
were instructed to maintain their habitual body weight,
food pattern and physical activity pattern in the first two
intervention periods and to consume only the vegetables
provided by TNO. To monitor food intake and compliance,
subjects wrote down their food intake for 3 days in the
second and fourth week of each treatment. Daily compli-
ance of vegetable consumption was registered as well. On
the day before each test day, all subjects consumed French
beans as a standardized meal to reduce variation in the
study samples.
Subjects
We selectively recruited apparently healthy, lean and
overweight/obese, non-smoking male subjects. Sixty-three
subjects came to TNO for an oral information session.
Forty-eight subjects signed an informed consent. Thirty-
nine subjects were eligible, and 34 subjects were included.
Two subjects dropped out during the study for non-study-
related reasons; therefore, the study was completed with 32
subjects. Fifteen subjects were lean (BMI 23.4 ±
1.7 kg m-2), and seventeen subjects were overweight/
obese (BMI 30.3 ± 2.4 kg m-2). Subjects were aged
between 18 and 45 years, exercised less than 2.5 h a week
and were used and liked to eat vegetables. Subjects
received financial compensation for their participation.
Experimental protocol
At the end of each 4-week intervention period, a test day
was conducted (day 29, 57 and 85).
On each test day, a fasted blood sample was obtained.
Physical variables like body weight, waist and hip
circumferences and blood pressure were measured.
A standard breakfast was provided after blood sampling.
A maximal exercise test was performed after breakfast
consumption. The results of the exercise tests will be
presented elsewhere.
Blood and urine clinical chemistry analyses
Blood samples were obtained from the antecubital vein of
the forearm and collected in tubes containing clot activator
for serum and in tubes containing EDTA for plasma
(Vacutainer Systems, Becton–Dickinson, Plymouth, U.K.).
Blood was centrifuged for 15 min at 2,000g and 4 C
within 30 min after collection. Plasma and serum samples
were stored at \-70 C until analysis.
Serum clinical chemistry tests included the measure-
ment of glucose, triacylglycerol (TG), free fatty acids
(FFA), glycerol, insulin, HbA1c, total cholesterol and
HDL-cholesterol, c-GT, ALAT, ASAT, ALP, hamatology,
total bilirubin, urea, uric acid, creatinine, lactate, creatine
kinase and myoglobin and were performed using Olympus
analytical equipment and reagents (Olympus AU400 clin-
ical chemistry analyzer; Olympus-Diagnostica Europe,
Hamburg, Germany).
Plasma samples of 10 lean and 10 obese subjects were
used for multiplex analysis of 6 inflammatory proteins:
GM-CSF, IFNgamma, IL-1beta, IL-6, IL-8 and TNF-alpha
(Mesoscale Discovery). Plasma levels of IFNgamma and
IL-1beta were too low and could not be detected.
Plasma profiling of oxylipins and amino acids
To monitor the effect of the vegetable intervention on
processes related to inflammation, oxidative stress, beta-
oxidation and protein and amino acid metabolism, blood
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samples were collected for liquid chromatography–mass
spectrometry (LC–MS) analysis of oxylipins and amino
acids after an overnight fast at the end of the 4-week low
and high vegetable interventions. For oxylipin analysis,
blood was collected in tubes containing EDTA. These
blood samples were directly supplemented with an inhibi-
tor cocktail containing paraoxon, butylated hydroxytoluene
(BHT), indomethacin and phenyl methyl sulfonylfluoride
(PMSF) with the following proportions 1 BHT: 1 Indo-
methacin: 10 Paraoxon: 1 PMSF to prevent oxylipin oxi-
dation and breakdown. For amino acid analysis, blood was
collected in tubes containing Li-heparin as anti-coagulant.
Blood was put on ice till centrifugation. All samples were
centrifuged within 30 min after collection. Blood was
centrifuged for 15 min at 2,000g and 4 C. Plasma and
serum samples were stored at \-70 C until analysis.
The LC–MS/MS method used for the measurement of
plasma oxylipins and the LC–MS method used for the
measurement of a broad range of plasma amino acids and
derivatives were identical to the methods reported by,
respectively, Balvers et al. (2012) and Rosenling et al.
(2009). The samples were analyzed in randomized order.
For amino acids, data for each subject were corrected for
the recovery of the internal standard for injection. The
performance of the applied metabolic profiling platforms
was assessed through the frequent analysis of the quality
control sample. Finally, the oxylipin data set contained 21
metabolites and the amino acid data set consisted of 51
metabolites (see Supplementary File 1).
Fat biopsy
After 3 weeks of treatment intervention, at day 22, 50 and
78, an abdominal, subcutaneous fat sample was obtained
after an overnight fast from all subjects. Human abdominal
fat biopsies were taken according to Kolaczynski et al.
(1994). Briefly, subcutaneous adipose tissue was obtained
by needle aspiration under local anesthesia using two
syringes of 50 mL 8.4 % NaHCO3, 0.05 % lidocaine and
1.0 mg/ml epinephrine. The two syringes used for fat
collection contained in total about 10 mL of adipose tissue.
The adipose tissue was divided over cryovials, immediately
frozen in liquid nitrogen and stored at -80 C for RNA
isolation (van Erk et al. 2008).
Transcriptomics
Total RNA was extracted from adipose tissue samples from
10 lean and 10 obese subjects (a subset of subjects in both
groups) using RNAzol (Campro Scientific, Veenendaal, the
Netherlands) and glass beads according to the manufac-
turer’s instructions. RNA was subjected to a cleanup step
using NucleoSpin columns (Macherey–Nagel, Germany).
Quality control, RNA labeling, hybridization and data
extraction were performed at ServiceXS (Leiden, the Neth-
erlands). RNA concentration was measured using a Nano-
drop ND-1000 spectrophotometer (Nanodrop Technologies,
Wilmington, DE, USA). The RNA quality and integrity was
determined using Lab-on-Chip analysis on an Agilent 2100
Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA,
USA). The Ambion Illumina total prep 96 kit was used to
create biotinylated cRNA from the RNA samples. For the
hybridization, wash and stain steps and scanning of the
Illumina BeadChips the Illumina protocol: ‘‘Whole-Genome
Gene Expression Direct Hybridization Assay’’ was followed
strictly. The amount of biotinylated cRNA hybridized onto
the HumanHT-12 v.3 Expression BeadChip was 750 ng. In
total, 60 RNA samples from adipose tissue were of sufficient
quality and subjected to array analysis.
Due to scanning problems for one sample, data of 19
subjects were included in further analysis.
Data were extracted using GenomeStudio. Quality con-
trol and normalization (quantile) of microarray data was
performed in Genespring GX11.0. Non-expressed genes
were removed by filtering on detection value (p value C0.99
in at least one sample). This resulted in gene expression
values for 21,525 genes with unique identifiers.
The microarray data will be made available in the GEO
database (http://www.ncbi.nlm.nih.gov/geo/).
Statistics
The number of subjects participating in the present study
was based on the main health biomarker ‘‘oxidative stress.’’
This parameter was tested with a maximal exercise per-
formance on a cycle ergometer, and therefore, the number
of subjects reported in the review of Fisher-Wellman and
Bloomer (2009) was used for the determination of group
size in the present study.
The vegetable interventions (health effect) were tested
according to the crossover design and the energy-restricted
period according to the parallel design. For the crossover
design, all variables were compared between treatments and
weight class with a mixed model that included treatment,
weight class and the interaction between weight class and
treatment as fixed factors and period and subject as random
factors. If the analysis indicated an interaction between
weight class (lean and obese) and treatment (p \ 0.05),
comparisons between means of the parameters were per-
formed using a 2-sided Student t test. A mixed model on the
difference between last measurement in the second inter-
vention period (last measurement in crossover design) and
the measurement after the third intervention (energy
restriction) was used to investigate the effect of the caloric
restriction. Although the statistics is performed on the
changes resulting from energy restriction (comparison of
510 Genes Nutr (2013) 8:507–521
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values after energy restriction period to values before energy
restriction period), to control for prior vegetable dose (high or
low), in the tables, the absolute values are presented.
If necessary, data were log-transformed and statistical
outliers (defined as an observation for which the absolute
residual was three times higher than the square root of the
model error) were removed. In all statistical tests per-
formed, the null hypothesis (no effect) was rejected at the
0.05 level of probability.
Expression data of the transcriptomics were log-trans-
formed (base 2). To reveal the effect of high vegetables, a
two-way ANOVA was applied with the following factors:
group (lean/obese), treatment (high vegetables/low vege-
tables) and interaction. If the ANOVA assumptions were
not met, data were rank-transformed and the ANOVA
model was applied on rank-transformed data. In all statis-
tical tests performed, the null hypothesis (no effect) was
rejected at the 0.05 level of probability. In addition to a
threshold on p value, a threshold was applied to fold
change induced by intervention. Genes were used for bio-
logical interpretation if the p value threshold was passed
and if the intervention resulted in more than 25 %
expression difference in same direction in at least 60 % of
the subjects (all up or all down).
Pearson correlation coefficients were calculated between
gene expression changes (2log ratio for after vs. before
energy restriction) and body weight change. Genes with
correlation coefficient above 0.7 or below -0.7 were
selected and submitted to enrichment analysis in DAVID
(Huang et al. 2009). When correlation was contributable to
one outlier value, these were not taken into account for
interpretation. Statistical analyses were performed using
the SAS statistical software package (SAS version 8.2,
SAS Institute, Cary, NC, USA).
Biological interpretation
Gene enrichment analysis was performed using DAVID
Functional enrichment tools (http://david.abcc.ncifcrf.gov/)
(Huang et al. 2009), selecting enriched gene groups
(p \ 0.05) with 5 or more differentially expressed genes.
Network analysis of genes, proteins and metabolites was
performed in MetaCore version 6.7 (GeneGo Inc., St.
Joseph, MI, USA), using the shortest path algorithm (max 2
steps). Prostaglandin D3 and Methionine sulfoxide were
not present in the MetaCore database and were therefore
excluded from network analysis.
Results
This study aimed to investigate the effect of high vegetable
consumption in lean and obese subjects compared to low
vegetable consumption. The baseline characteristics and
fasting blood data of the subjects are shown in Table 1. Not
only body weight, BMI, waist circumference and waist–hip
ratio were different between lean and obese group, but also
levels of insulin, total cholesterol and LDL cholesterol. All
these parameters were significantly higher in the obese
compared to the lean group.
Compliance in the study
Compliance of vegetable consumption was evaluated at the
end of the vegetable treatments, by registration of the daily
intake of the vegetables. If study substances were not
consumed or the amount was not equal to the required 50
or 200 g, this was registered as a protocol deviation. In the
two times 4-week treatment period, the 32 subjects were
supposed to consume 1,792 portions of vegetables in total.
Twenty vegetable consumption protocol deviations (more
or less vegetable intake, evenly divided (some forgot, some
consumed more)) were registered and therefore compliance
for vegetable intake was 98.9 %. When the 16 fruit intake
deviations were taken into account as well (mainly con-
sumption of two pieces of fruit in stead of one) (in total 36
fruit and vegetable consumption deviations were reported),
compliance was still 98.0 %. Compliance to vegetable
treatment was therefore qualified as good.
During the energy-restricted intervention, subjects were
instructed to consume about 30–40 % less energy daily
(individual advices were given by the dietitian), which was
Table 1 Baseline characteristics and fasting blood data of the lean
(n = 15) and obese (n = 17) men who completed the study






Age (years) 36 ± 7 40 ± 6 N.S.
Body weight (kg) 82.9 ± 9.2 101.4 ± 11.4 \0.001
BMI (kg m-2) 23.4 ± 1.7 30.3 ± 2.4 \0.001
Waist circumference (cm) 88.9 ± 4.8 105.6 ± 6.6 \0.001
Waist–hip ratio 0.89 ± 0.04 0.97 ± 0.04 \0.001
Systolic blood pressure
(mm Hg)
120 ± 13 127 ± 12 N.S.
Diastolic blood pressure
(mm Hg)
79 ± 9 83 ± 11 N.S.
Glucose (mmol/L) 5.5 ± 0.4 5.6 ± 0.4 N.S.
Insulin (mmol/L) 6.2 ± 2.4 12.9 ± 6.5 \0.05
HbA1c (%) 5.1 ± 0.2 5.0 ± 0.2 N.S.
Total cholesterol (mmol/L) 4.9 ± 0.6 5.7 ± 0.7 \0.05
HDL-cholesterol (mmol/L) 1.3 ± 0.3 1.2 ± 0.2 ?
LDL-cholesterol (mmol/L) 3.0 ± 0.4 3.6 ± 0.5 \0.05
? Represents a tendency (p \ 0.1); N.S. means not significant
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calculated to result in *1 kg weight loss per week. The
caloric restriction intervention resulted in weight loss in
lean and obese subjects (-1.7 ± 2.4 kg in lean and
-2.1 ± 1.9 kg in obese). The weight loss was significant
over time (p \ 0.0001), but not different between the lean
and obese. This amount of weight loss was about 50 % of
the amount expected after 4 weeks of energy restriction;
therefore, the compliance was also about 50 %. The com-
pliance during the energy-restricted diet period was there-
fore qualified as moderate.
Plasma markers
The caloric restriction intervention was used as a positive
control condition to evaluate the effects found with the
vegetable interventions. Tables 2 and 3 indicate the plasma
marker changes in response to the caloric restriction and
the vegetable intervention, respectively. Overall, the
changes were not different between lean and obese sub-
jects; very few markers showed a significant different
response in obese compared to lean subjects (significant
interaction in ANOVA).
Blood levels of total cholesterol, LDL cholesterol, ratio
of cholesterol/HDL, c-GT, ASAT and HbA1c decreased
significantly in response to the energy restriction diet in
both lean and obese groups (Table 2).
Only fasting ASAT and ALP levels were lower after
consumption of 200-g vegetables compared to 50-g vege-
tables in both lean and obese subjects (Table 3). TNF-a, an
inflammation marker, showed an interaction between
weight class and treatment: TNF-a levels were
significantly lower in lean men after 200 g of vegetable
treatment compared to the 50 g of vegetable treatment.
The inventory of health-promoting effects of vegetables
in lean and obese subjects included measurements of
plasma metabolites related to amino acids and derivatives
(n = 51) and oxylipins (n = 21) (see Supplementary File
1) and measurement of 4 inflammatory plasma proteins
(IL-6, IL-8, TNF-a and GM-CSF). The plasma metabolites
with a significant change related to vegetable intake are
summarized in Table 4. Intake of 200 g compared to 50-g
vegetables resulted in increased plasma levels of aspara-
gine (?6.8 %), leucine (?5.0 %), methionine sulfoxide
(?15 %) and threonine (?5.9 %). Levels of 9-HODE
(-21.4 %) and prostaglandin D3 (-16.7 %) were signifi-
cantly lower in response to the 200-g vegetable intake
compared to 50-g vegetable intake. Uniquely in obese
subjects, levels of 15-HETE were lowered (-31.7 %).
Vegetable intake did not result in significant changes in
inflammatory plasma proteins IL-6, IL-8, TNF-a and GM-
CSF in this selected group of subjects and analysis.
Effects of increased vegetable intake on adipose tissue
We aimed to investigate the effect of increased vegetable
intake on adipose tissue in lean and obese subjects by gene
expression analysis. Overall, limited gene expression
changes were observed due to high vegetable intake com-
pared to low vegetable intake: 323 genes were affected in
obese subjects and 532 genes in lean. The differentially
expressed genes in lean subjects were enriched for genes
involved in immune and inflammatory response. In lean
Table 2 Changes in blood parameters after the energy-restricted (ER) intervention (mean ± SD is presented)
Treatment Lean (n = 15) Obese (n = 17) p value#
Before ER After ER Before ER After ER
Glucose (mmol/L) 5.4 ± 0.3 5.5 ± 0.3 5.7 ± 0.3 5.7 ± 0.4 N.S.
Insulin (mU/L) 5.9 ± 3.3 5.0 ± 2.7 12.7 ± 6.1 11.0 ± 6.8 N.S.
HbA1c (%) 5.1 ± 0.2 5.0 ± 0.2 5.1 ± 0.2 5.0 ± 0.1 \0.05
Total cholesterol (mmol/L) 5.2 ± 0.7 4.7 ± 0.7 6.0 ± 0.7 5.4 ± 0.5 \0.05
HDL-cholesterol (mmol/L) 1.3 ± 0.4 1.3 ± 0.3 1.2 ± 0.2 1.1 ± 0.2 N.S.
LDL-cholesterol (mmol/L) 3.3 ± 0.6 2.9 ± 0.6 3.9 ± 0.6 3.5 ± 0.4 \0.05
Ratio cholesterol/HDL 4.3 ± 1.2 3.8 ± 0.9 5.3 ± 0.9 4.9 ± 0.9 \0.05
Triacylglycerol (mmol/L) 1.4 ± 0.7 1.1 ± 0.5 2.2 ± 1.2 2.1 ± 1.4 N.S.
c-GT (U/L) 23.4 ± 11.2 18.2 ± 8.0 33.9 ± 12.8 27.5 ± 12.5 \0.05
ALAT (U/L) 12 ± 4 12 ± 4 19 ± 11 19 ± 11 N.S.
ASAT (U/L) 21 ± 4 20 ± 4 26 ± 8 24 ± 6 ?
ALP (U/L) 64 ± 12 60 ± 10 67 ± 18 65 ± 14 N.S.
TNF-a (pg/mL)a 0.97 ± 0.29 0.88 ± 0.18 1.08 ± 0.34 1.11 ± 0.39 N.S.
# p values for treatment effect in 2-way ANOVA, interaction effects (BMI-category 9 treatment) were not significant
? p \ 0.1 (tendency)
a Two lean subjects were excluded from the TNF-a dataset because they were outliers, ER energy restriction
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subjects, high vegetable consumption resulted in reduced
expression of adipose tissue genes IL-8 and NFKB2 and
increased expression of adipose tissue genes complement
component 3 (C3) and NFKB inhibitor NFKBIB. The
Table in Supplementary File 2 lists the 40 differentially
expressed genes in lean subjects annotated to these pro-
cesses. In obese subjects, no gene ontology biological
processes were enriched in the set of 323 genes.
We investigated to what extent adipose tissue gene
expression changes in response to caloric restriction were
associated with weight loss. Weight loss in response to
caloric restriction was similar to lean and obese subjects.
However, very limited gene expression changes were
associated with amount of weight loss when all subjects
were taken together (6 genes with r [ |0.7|, data not
shown). Next, lean and obese subjects were analyzed
separately, to check for correlations within these groups. In
the group of obese subjects, 641 genes showed high cor-
relation (r [ |0.7|) to body weight change compared to 303
genes in the group of lean subjects. Enrichment analysis
showed that in obese subjects, body weight change due to
caloric restriction intervention correlated with gene
Table 3 Changes in blood clinical chemistry parameters after the vegetable intervention (mean ± SD is presented)
Treatment Lean (n = 15) Obese (n = 17) p value#
50-g Veg 200-g Veg 50-g Veg 200-g Veg
Glucose (mmol/L) 5.4 ± 0.3 5.4 ± 0.3 5.7 ± 0.4 5.9 ± 0.1 N.S.
Insulin (mU/L) 5.5 ± 2.6 5.9 ± 3.2 11.0 ± 5.2 13.4 ± 6.7 N.S.
HbA1c (%) 5.1 ± 0.2 5.1 ± 0.2 5.1 ± 0.1 5.1 ± 0.2 N.S.
Total cholesterol (mmol/L) 5.1 ± 0.7 5.2 ± 0.6 6.0 ± 0.8 5.8 ± 0.7 N.S.
HDL-cholesterol (mmol/L) 1.3 ± 0.3 1.3 ± 0.3 1.2 ± 0.2 1.1 ± 0.2 N.S.
LDL-cholesterol (mmol/L) 3.2 ± 0.6 3.4 ± 0.4 3.9 ± 0.6 3.8 ± 0.6 N.S.
Ratio cholesterol/HDL 4.2 ± 1.2 4.2 ± 0.9 5.3 ± 0.9 5.3 ± 0.9 N.S.
Triacylglycerol (mmol/L) 1.3 ± 0.7 1.2 ± 0.5 2.2 ± 1.2 2.2 ± 1.7 N.S.
c-GT (U/L) 23.3 ± 10.9 22.4 ± 10.8 34.3 ± 13.1 32.9 ± 11.6 N.S.
ALAT (U/L) 13 ± 4 11 ± 4 21 ± 15 21 ± 10 N.S.
ASAT (U/L) 21 ± 4 20 ± 4 26 ± 8 25 ± 8 \0.05
ALP (U/L) 63 ± 11 61 ± 11 67 ± 18 64 ± 15 \0.05
TNF-a (pg/mL)a 1.03 ± 0.28 0.84 ± 0.17 1.11 ± 0.41 1.09 ± 0.36 0.0067*
# p values for treatment effect in 2-way ANOVA, interaction effects (BMI-category 9 treatment) were not significant
* p value for vegetable effect in lean subjects (post hoc test); p value for interaction (BMI-category 9 treatment) was 0.0491
a Two lean subjects were excluded from the TNF-a dataset because they were outliers; g, gram and Veg, vegetable
Table 4 Significant changes in blood metabolites after the vegetables intervention (mean ± SD is presented)
Treatment Lean (n = 15) Obese (n = 17) p value#
50-g Veg 200-g Veg 50-g Veg 200-g Veg
Asparagine
(Asn)
0.30 ± 0.06 0.32 ± 0.06 0.28 ± 0.05 0.30 ± 0.07 0.0418
Leucine (Leu) 1.61 ± 0.13 1.65 ± 0.15 1.83 ± 0.33 1.96 ± 0.36 0.0224
Methionine
sulfoxide 1
1.9 9 10-3 ± 8.8 9 10-4 2.2 9 10-3 ± 2.9 9 10-4 1.9 9 10-3 ± 3.7 9 10-4 2.2 9 10-3 ± 5.7 9 10-4 0.0308
Methionine
sulfoxide 2
2.7 9 10-3 ± 1.2 9 10-3 2.9 9 10-3 ± 4.2 9 10-4 2.6 9 10-3 ± 6.7 9 10-4 3.1 9 10-3 ± 7.2 9 10-4 0.0455
Threonine (Thr) 2.32 ± 0.25 2.37 ± 0.28 2.26 ± 0.39 2.49 ± 0.53 0.0205
9-HODE 2.62 ± 0.83 2.20 ± 1.30 3.00 ± 1.31 2.21 ± 0.46 0.0187
PGD-3 0.024 ± 0.024 0.020 ± 0.021 0.017 ± 0.016 0.013 ± 0.016 0.0408
15-HETE 0.08 ± 0.03 0.10 ± 0.05 0.12 ± 0.06 0.08 ± 0.04 0.0263*
G gram; Veg vegetable
# p values for treatment effect in 2-way ANOVA, interaction effects (BMI-category 9 treatment) were not significant
* p value for vegetable effect in obese subjects (post hoc test); p value for interaction (BMI-category 9 treatment) was 0.006
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expression responses in processes of energy metabolism
(oxidative phosphorylation, mitochondrion, generation of
precursor metabolites and energy, regulation of lipid
metabolism), focal adhesion and inflammation (T cell
activation) in adipose tissue (Fig. 1). In lean subjects,
mainly gene expression changes related to inflammatory
response processes correlated with body weight change.
However, these were contributable to outlier values for 1
subject and therefore not taken into account further.
Although we were not able to detect enriched processes
related to vegetable intake in obese subjects based on the
set of 323 differentially expressed genes (see above), we
now investigated whether in obese subjects, the increased
vegetable consumption did affect expression of genes
annotated to the processes that were associated with weight
loss in obese subjects. Table 5 lists differentially expressed
genes (consistent expression change, i.e. [25 % up or
[25 % down in at least 6 subjects, combined with
p \ 0.05 in ANOVA) in response to high vegetable intake
compared to low vegetable intake involved in energy
metabolism, adhesion and inflammation in obese subjects.
This resulted in 16 genes for energy metabolism, 18 genes
for cell adhesion and 19 genes for inflammation.
Data integration
We performed network analysis based on biological
knowledge using MetaCore software to integrate the data,
from plasma as well as adipose tissue.
In lean subjects, high vegetable intake resulted in dif-
ferential expression of 40 genes annotated to immune-
related processes. The biological network in Fig. 2 shows
direct interactions between 15 of these genes and plasma
TNF-alpha, with transcription factor NFkB as a central
regulator. Furthermore, network analysis showed that
9-HODE (measured in plasma) may be linked to this net-
work through PPARc. Potential anti-inflammatory effects
of high vegetable intake in lean subjects are supported by
down-regulation of NF-kB and target genes like tissue
factor and IL-8 in adipose tissue as well as down-regulation
of TNF-alpha levels in plasma.
To illustrate possible biological links between observed
effects of high vegetable intake on obese subjects, bio-
logical networks on the basis of inflammation, energy
metabolism and adhesion genes from Table 4 together with
the significantly changed plasma metabolites and classical
markers were created. The network in Fig. 3 shows that the
inflammatory gene expression changes due to vegetable
intervention in adipose tissue may be regulated by NFkB
and PPARc and that 9-HODE and 15-HETE (measured in
plasma) may be linked to this network through PPARc. All
but two inflammatory genes listed in Supplementary File 2
are connected in the network. Furthermore, the network in
Fig. 4 illustrates a biological link between 9-HODE and
15-HETE and specific energy metabolism genes, also
through PPARc. In addition to PPARc, many other tran-
scription factors may be involved in the regulation of
energy metabolism in obese subjects, for example, CREB1,
STAT5A, ESR2, ESR1 and SP1. Through these regulators,
the plasma markers ASAT (AATC) and ALP (ALPL) were
also linked to this network.
Biological network analysis did not reveal a link
between the expression changes of adhesion genes and the
plasma biomarker changes (see Supplementary File 3).
Discussion
By integration of sensitive omics technologies with classic
and modern metabolome biomarkers, we were able to show
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0
Oxidative phosphorylation (KEGG hsa00190)
Mitochondrion (GO-CC)
Oxidative phosphorylation (GO-BP)
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Negative regulation of lipid metabolic process (GO-BP)
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Fig. 1 Enrichment analysis of
641 genes with high correlation
to body weight change in 10
obese subjects
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Table 5 Expression changes in obese subjects in response to high vegetable intake compared to low vegetable intake related to inflammation,
energy metabolism and adhesion





Glutamate-ammonia ligase (glutamine synthetase) (GLUL), transcript variant 3,
mRNA
GLUL ILMN_1765208 2752 0.67 a
Runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
(RUNX1T1), transcript variant 3, mRNA
RUNX1T1 ILMN_1710522 862 0.65 a
Peroxisome proliferator-activated receptor gamma, coactivator-related 1
(PPRC1), mRNA
PPRC1 ILMN_1796210 23082 0.65 b
SLIT-ROBO Rho GTPase activating protein 2 (SRGAP2), transcript variant 1,
mRNA
SRGAP2 ILMN_1759549 23380 0.57 b
Pyruvate carboxylase (PC), nuclear gene encoding mitochondrial protein,
transcript variant 3, mRNA
PC ILMN_1736689 5091 0.44 a
FERM domain containing 6 (FRMD6), transcript variant 2, mRNA FRMD6 ILMN_2330787 122786 0.42 b
Solute carrier family 25, member 29 (SLC25A29), nuclear gene encoding
mitochondrial protein, mRNA
SLC25A29 ILMN_2350801 123096 0.40 b
Solute carrier family 25 (mitochondrial carrier, brain), member 14 (SLC25A14),
nuclear gene encoding mitochondrial protein, transcript variant long, mRNA
SLC25A14 ILMN_1743770 9016 0.39 a
Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain (ACADS), nuclear
gene encoding mitochondrial protein, mRNA
ACADS ILMN_1795104 35 -0.27 b
DNA replication helicase 2 homolog (yeast) (DNA2), mRNA DNA2 ILMN_2282959 1763 -0.57 b
Protein kinase C, alpha binding protein (PRKCABP), mRNA PRKCABP ILMN_1708159 9463 -0.67 a
Apolipoprotein O-like (APOOL), mRNA APOOL ILMN_1777483 139322 -0.68 a
Acyl-CoA synthetase medium-chain family member 5 (ACSM5), mRNA ACSM5 ILMN_1801698 54988 -0.71 a
Estrogen receptor 2 (ER beta) (ESR2), transcript variant b, mRNA ESR2 ILMN_2390457 2100 -0.74 a
PREDICTED: coiled-coil domain containing 56 (CCDC56), misc RNA CCDC56 ILMN_1789786 28958 -0.86 a
Component of oligomeric golgi complex 8 (COG8), mRNA COG8 ILMN_1725246 84342 -1.09 b
Adhesion
Presenilin 1 (Alzheimer disease 3) (PSEN1), mRNA PSEN1 ILMN_1796669 5663 1.13 a
PREDICTED: p21 (CDKN1A)-activated kinase 2 (PAK2), mRNA PAK2 ILMN_1659878 5062 0.96 a
Reelin (RELN), transcript variant 1, mRNA RELN ILMN_1753005 5649 0.89 b
LIM and senescent cell antigen-like domains 1 (LIMS1), mRNA LIMS1 ILMN_2381037 3987 0.71 b
Dystonin (DST), transcript variant 1e, mRNA DST ILMN_1675992 667 0.70 a
Rap guanine nucleotide exchange factor (GEF) 1 (RAPGEF1), transcript variant
2, mRNA
RAPGEF1 ILMN_1678799 2889 0.50 a
Protocadherin 9 (PCDH9), transcript variant 2, mRNA PCDH9 ILMN_2379626 5101 0.46 b
Phosphoglucomutase 5 (PGM5), mRNA PGM5 ILMN_2271149 5239 0.45 b
Periostin, osteoblast specific factor (POSTN), mRNA POSTN ILMN_1790761 10631 0.44 b
Claudin 15 (CLDN15), transcript variant 2, mRNA CLDN15 ILMN_1708267 24146 0.38 a
PREDICTED: p21 (CDKN1A)-activated kinase 2 (PAK2), mRNA PAK2 ILMN_1676385 5062 0.38 a
Polycystic kidney and hepatic disease 1 (autosomal recessive) (PKHD1),
transcript variant 1, mRNA
PKHD1 ILMN_1720034 5314 -0.30 b
Cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog,
Drosophila) (CELSR1), mRNA
CELSR1 ILMN_1694482 9620 -0.50 b
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
(AKT3), transcript variant 2, mRNA
AKT3 ILMN_1733598 10000 -0.59 b
Junction plakoglobin (JUP), transcript variant 2, mRNA JUP ILMN_2366864 3728 -0.67 a
Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);
translocated to, 4 (MLLT4), transcript variant 3, mRNA
MLLT4 ILMN_1746277 4301 -0.77 b
Cadherin-like 24 (CDH24), transcript variant 1, mRNA CDH24 ILMN_1693928 64403 -0.83 a
Rap guanine nucleotide exchange factor (GEF) 1 (RAPGEF1), transcript variant
1, mRNA
RAPGEF1 ILMN_1695282 2889 -0.93 b
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health effects of increased vegetable intake in both lean
and obese subjects and elucidate some of the underlying
mechanisms. The responsive markers included classical
markers ASAT and ALP, plasma amino acids and oxyli-
pins quantified by metabolic profiling as well as adipose
tissue gene expression. The latter results suggest that both
vegetable intake and weight reduction is differently regu-
lated in lean and obese subjects. Data integration through
network analysis illustrated a central role for NFkB in
(adipose tissue) modulation of inflammation by increased
vegetable intake, in lean as well as obese subjects. Plasma
inflammatory cytokines did not change in response to
increased vegetable intake, with the exception of TNF-a
that showed lower concentrations in lean subjects. In obese
subjects, high vegetable intake also resulted in adipose
tissue gene expression changes related to energy metabo-
lism and cell adhesion.
Subjects consumed both fresh and canned vegetables;
the types of vegetables offered were the most popular
types: (fresh) tomatoes, cauliflower, beet, onions; (canned)
peas, broad beans, French beans, carrots, corn. Body
weight remained stable through both high and low
vegetable intakes. The finding that the highest treatment
dose of 200 g of vegetables daily affects physiological
processes in a direction that is associated with health
benefits supports the advice on the Dutch Health Council to
consume 200 g of vegetables daily (Health Council of the
Netherlands 2006). Higher dosages of vegetables could
scientifically be even more interesting; however, this will
be considerably challenging for public health implemen-
tation and probably not yet realistic. In public surveys, it
was found that on average about 2 % of the Dutch popu-
lation consume 150 g of vegetables daily, and therefore,
even 200 g daily may already provide a challenging target.
In the present study investigating health effects of
vegetables, an energy restriction intervention was included
to determine whether similar processes are present and
similar effects on health were found. Although the subjects
did not lose a lot of weight, still beneficial health effects
were seen at the level of classical markers including weight
loss, decreases in total cholesterol, LDL cholesterol, ratio
of cholesterol/HDL and HbA1c. It was already known that
about 5 % weight loss is beneficial for health (Wing et al.
1992; Tuomilehto et al. 2001; Calder et al. 2011). We
Table 5 continued





Presenilin 1 (Alzheimer disease 3) (PSEN1), mRNA PSEN1 ILMN_1796669 5663 1.13 a
Cathepsin C (CTSC), transcript variant 2, mRNA CTSC ILMN_1689086 1075 0.78 b
Membrane-associated ring finger (C3HC4) 8 (MARCH8), transcript variant 6,
mRNA
MARCH8 ILMN_2341626 220972 0.78 a
Interleukin 7 receptor (IL7R), mRNA IL7R ILMN_2342579 3575 0.73 a
Interleukin 8 (IL8), mRNA IL8 ILMN_2184373 3576 0.66 a
Tumor necrosis factor receptor superfamily, member 13C (TNFRSF13C),
mRNA
TNFRSF13C ILMN_1731742 115650 0.63 a
Colony stimulating factor 1 (macrophage) (CSF1), transcript variant 4, mRNA CSF1 ILMN_1805930 1435 0.52 b
Epstein-Barr virus-induced 3 (EBI3), mRNA EBI3 ILMN_1802653 10148 0.51 a
Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
(APOBEC3F), transcript variant 1, mRNA
APOBEC3F ILMN_1710726 200316 0.49 b
Neutrophil cytosolic factor 1 (NCF1), mRNA NCF1 ILMN_1697309 653361 0.38 a
Cathepsin C (CTSC), transcript variant 1, mRNA CTSC ILMN_2242463 1075 0.34 b
B and T lymphocyte associated (BTLA), transcript variant 1, mRNA BTLA ILMN_1778536 151888 -0.19 a
Chemokine (C-X-C motif) receptor 5 (CXCR5), transcript variant 2, mRNA CXCR5 ILMN_2337931 643 -0.42 a
Interleukin 1 receptor, type II (IL1R2), transcript variant 2, mRNA IL1R2 ILMN_1772131 7850 -0.60 b
Lymphocyte transmembrane adaptor 1 (LAX1), mRNA LAX1 ILMN_1769782 54900 -0.61 a
Serum amyloid A1 (SAA1), transcript variant 1, mRNA SAA1 ILMN_1701017 6288 -0.68 b
Virus-induced signaling adapter (VISA), mRNA VISA ILMN_2131493 57506 -0.69 a
Tumor necrosis factor (ligand) superfamily, member 12 (TNFSF12), transcript
variant 2, mRNA
TNFSF12 ILMN_1680003 8742 -0.75 a
Serum amyloid A1 (SAA1), transcript variant 1, mRNA SAA1 ILMN_1808732 6288 -1.29 a
a: p for interaction between intervention and group \0.05; b: p for intervention \0.05. Genes showed consistent expression change in obese
subjects ([25 % up or [25 % down in at least 6 subjects)





Fig. 2 Network showing biological links between genes involved in
inflammation and plasma markers that respond to high vegetable
intake in lean subjects. Red circle indicates up-regulation in response
to high vegetable intake, blue circle indicates down-regulation in
response to high vegetable intake. BAFF-R tumor necrosis factor
receptor superfamily, member 13C; Bcl-3 B cell CLL/lymphoma 3;
C3 complement component 3; CCL28 chemokine (C–C motif) ligand
28; CCR10 chemokine (C–C motif) receptor 10; CSF1 colony
stimulating factor 1 (macrophage); Factor H complement factor H;
IL-8: interleukin 8; MASP1: mannan-binding lectin serine peptidase 1
(C4/C2 activating component of Ra-reactive factor); NF-kB: nuclear
factor-kappa-B; NFKBIB I-kappa-B-beta; PPAR-c peroxisome pro-
liferator-activated receptor gamma; TNF-a tumor necrosis factor




Fig. 3 Network showing biological links between genes involved in
inflammation and plasma markers that respond to high vegetable
intake in obese subjects. Red circle indicates up-regulation in
response to high vegetable intake, blue circle indicates down-
regulation in response to high vegetable intake. APOBEC3F:
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like
3F; BAFF-R tumor necrosis factor receptor superfamily, member
13C; CSF1 colony stimulating factor 1 (macrophage); EBIB Epstein–
Barr virus-induced 3, IL-27 subunit beta; CXCR5 chemokine (C-X-C
motif) receptor 5; 15(S)-HETE 15-HETE; IL1R2: interleukin-1
receptor type 2; IL-8 interleukin-8; IL-27 interleukin-27; IL-35
interleukin-35; LAX1 lymphocyte transmembrane adaptor 1; Lck
tyrosine-protein kinase Lck; MARCH8 (c-MIR) membrane-associated
ring finger (C3HC4) 8; NF-kB nuclear factor-kappa-B; p47-phox
neutrophil cytosolic factor 1; PPAR-c peroxisome proliferator-
activated receptor gamma; RXR-a retinoid X receptor, alpha; SAA1
serum amyloid A1; STAT1 signal transducer and activator of
transcription 1; STAT5 signal transducer and activator of transcription
5; TRAF3 TNF receptor-associated factor 3; VISA mitochondrial
antiviral signaling protein
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report in the present study that 2 % body weight loss sig-
nificantly affects established biomarkers of (cardiovascu-
lar) health.
After 8 weeks of prescribed vegetable consumption,
subjects were instructed to eat in total less energy. The
energy-restricted diet intervention was deliberately
designed at the end of the study for all subjects, because we
expected clear physiological impact due to energy restric-
tion. This could not be implemented during the low/high
vegetable intake intervention because it would have influ-
enced the differences in vegetable intake. As a period ad
random in the crossover trial, it would have affected the
vegetable interventions too much, and therefore, only the
vegetable interventions were designed as a crossover with
an energy-restricted period afterward for all subjects.
In contrast to the energy restriction intervention, plasma
markers did not show clear health benefits due to increased
vegetable consumption. Two liver enzymes, ALP and
ASAT, showed decreased concentrations after 4 weeks of
200 g of vegetable consumption. In lean subjects, the TNF-
a level decreased with high vegetable consumption. The
sensitive metabolic profiling analyses showed additional
health effects. High vegetable intake resulted in signifi-
cantly increased plasma levels of four amino acids
(derivatives): asparagine, leucine, methionine sulfoxide
and threonine. The amino acids may directly originate from
the consumed vegetables and thus leading to increased
plasma levels. So far, only O’Sullivan reported on dietary
intake patterns among which vegetable consumption and
their reflection in plasma and urinary metabolic profiles
(O’Sullivan et al. 2011). Unfortunately, nothing was
reported on vegetable intake and their plasma reflection on
amino acids, so therefore, this finding could not be con-
firmed. Methionine sulfoxide is a well-known biomarker
for oxidative stress, which occurs by oxidation of methio-
nine residues to methionine sulfoxide (Mashima et al.
2003). It can be produced in vivo, but it is also known that
plants produce this metabolite in response to stress (Emes
2009), since the relative response of this plasma metabolite
to an a maximal exercise challenge is significantly lower in
the subjects on high vegetables compared to low vegetables
in this study, which was interpreted that high vegetables
protected subjects from the acute in vivo damage by oxi-





Fig. 4 Network showing biological links between genes involved in
energy metabolism and plasma markers that respond to high
vegetable intake in obese subjects. Red circle indicates up-regulation
in response to high vegetable intake, blue circle indicates down-
regulation in response to high vegetable intake. AATC glutamic-
oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1);
ALPL alkaline phosphatase, liver/bone/kidney; C/EBP CCAAT/
enhancer binding protein (C/EBP); COG complex component of
oligomeric golgi complex; COG5 component of oligomeric golgi
complex 5; COG8 component of oligomeric golgi complex 8; CREB1
cAMP responsive element binding protein 1; c-Myc v-myc myelo-
cytomatosis viral oncogene homolog (avian); ESR1 (nuclear)
estrogen receptor 1; ESR2 estrogen receptor 2 (ER beta); ETO runt-
related transcription factor 1; translocated to, 1 (cyclin D-related);
FKHR forkhead box O1; GATA-1 GATA binding protein 1 (globin
transcription factor 1); GLNA glutamate-ammonia ligase; 15(S)-
HETE 15S-hydroxyeicosatetraenoic acid; 15-HETE 15-hydroxyeico-
satetraenoic acid; HOXA10 homeobox A10; PPAR-c peroxisome
proliferator-activated receptor gamma; RXR-a retinoid X receptor,
alpha; PRC (PGC-1 related) peroxisome proliferator-activated recep-
tor gamma, coactivator-related 1; PYC pyruvate carboxylase; SP1 Sp1
transcription factor; SRGAP2 SLIT-ROBO Rho GTPase activating
protein 2; STAT5A signal transducer and activator of transcription 5A;
Willin FERM domain containing 6
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that processing of foods can lead to modifications of pro-
teins by oxidation, such as methionine sulfoxide (Ruther-
furd and Moughan 2008). Taken together, we interpreted
the significant increase in plasma methionine sulfoxide
concentrations likely to be due to the higher intake of
processed vegetables. Levels of lipid-derived metabolites
9-HODE, 15-HETE and prostaglandin D3 decreased in
response to the 200-g vegetable intake compared to 50-g
vegetable intake. 9-HODE and 15-HETE are both reduced
products synthesized from, respectively, linoleic acid and
arachidonic acid in the 12- and 15-lipoxygenase (LOX)
pathways. These pathways are associated with LDL oxi-
dation and subsequently with atherosclerotic lesions
(Imaizumi et al. 2010). 9(S)-HODE and 13(S)-HODE are
known as lipid peroxidation markers that can be used for
the estimation of oxidative stress in human (Spiteller and
Spiteller 1997). The oxylipin 13(S)-HODE showed a trend
for treatment effect (p value 0.0543) with similar direction
as 9-HODE and 15-HETE. Therefore, decreased concen-
trations of products from the 12- and 15-LOX pathways
suggest decreased oxidative stress in subjects in response to
high vegetable intake. This illustrates that subtle, beneficial
processes take place and can be shown with this technology
when classical markers do not show any effect.
In addition to the plasma metabolic profiling, we studied
effects of the nutritional interventions in adipose tissue by
whole-genome expression profiling. Previously, we and
others have shown that nutritional intervention can result in
adipose tissue gene expression changes (van Erk et al.
2008; Radonjic et al. 2009), including effects on inflam-
matory processes. Furthermore, it is expected that energy
restriction and body weight loss result in changes in adi-
pose tissue, specifically in obese subjects (Ma´rquez-Quin˜-
ones et al. 2010; Bouchard et al. 2010). In obese subjects,
weight loss due to the energy restriction was associated
with changes in processes related to energy metabolism:
oxidative phosphorylation, mitochondrial function, gener-
ation of precursor metabolites and energy. Also, process of
adhesion and T cell activation (inflammation) were chan-
ged in concordance with weight loss. These processes are
also reported in studies investigating adipose tissue
response to very-low-calorie diets in obese subjects (Cle´-
ment et al. 2004; Franck et al. 2011).
High vegetable intake resulted in subtle gene expression
changes in adipose tissue. We selected differentially
expressed genes based on statistics combined with a fold
change threshold ([25 % up or [25 % down in at least 6
subjects). This approach takes into account inter-individual
variation in response while still identifying group effects of
a certain effect size. By submitting the selected sets of
differentially expressed genes to enrichment analysis, we
could identify the biological processes affected by
increased vegetable intake. In lean subjects, increased
vegetable consumption affected adipose tissue inflamma-
tion, as measured by gene expression. Through network
analysis based on biological knowledge, we could visualize
direct links between 15 adipose tissue genes with a role in
inflammation. These genes were directly linked to TNF-
alpha, for which plasma levels were decreased by increased
vegetable intake in lean subjects. Within the group of obese
subjects, increased vegetable intake resulted in a smaller
set of differentially expressed genes that was not enriched
for biological processes. This may be due to a larger var-
iation in response to the obese group of subjects. We have
seen such a larger response variation (factor two different)
in a previous study as well (van Erk et al. 2008).
Weight loss is a well-accepted health benefit for obese
subjects (Wing et al. 1992; Tuomilehto et al. 2001; Calder
et al. 2011). By correlating adipose tissue gene expression
changes to body weight change after caloric restriction, we
identified pathways or processes that are associated with
this health benefit. These processes were only identified in
the obese subjects. This makes sense as these subjects,
being overweight, would benefit most from weight loss. In
obese subjects, high vegetable intake resulted in differen-
tial expression of small sets of genes in all three processes:
adhesion, energy metabolism and inflammation. In order to
visualize biological links between these adipose tissue
genes, plasma proteins and plasma metabolites, biological
network analysis was performed The plasma metabolites
related to amino acids were included in the network but did
not appear to be involved in the inflammation processes.
The network of inflammation genes revealed a central role
of NFkB as regulator of inflammatory gene expression
changes in adipose tissue due to high vegetable intake.
Therefore, it could be hypothesized that in both lean and
obese subjects, increased vegetable intake affects inflam-
matory processes in adipose tissue through NFkB. Also, the
networks show a link of these adipose tissue inflammatory
responses with decreases in plasma oxylipins 9-HODE and
15-HETE, through PPARc/RXRa. These oxylipins are
known to play a role in oxidative stress.
The network of energy metabolism genes also shows a
connection to plasma oxylipins through PPARc/RXRa.
This network includes a range of transcription factors that
could be involved rather than one central regulator for
inflammation. Interestingly, this network includes ASAT
(AATC) and ALP (ALPL), indicating a potential biological
link between these markers and adipose tissue gene
expression changes related to energy metabolism.
The network of adhesion genes did only reveal a link to
plasma ALP and not to other plasma markers or central
regulators.
Network analysis has the advantage of combined anal-
ysis of markers from different levels (gene, protein,
metabolite) and of focus on biological connections between
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markers that show a significant response. The networks
provide hypotheses of possible effects and mechanisms of
health-promoting effects of high vegetable intake that can
be investigated in more detail.
Conclusion
By inclusion of sensitive omics technologies and compar-
ing the changes induced by high vegetable intake with
changes induced by energy restriction and associated with
weight loss, it has been shown that part of vegetables’
health benefits are mediated by changes in energy metab-
olism, inflammatory processes and oxidative stress.
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